Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 6
1998 7
1999 5
2000 7
2002 5
2003 2
2004 3
2005 3
2006 4
2007 1
2010 2
2011 1
2013 2
2018 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

57 results
Results by year
Filters applied: . Clear all
Page 1
Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial.
Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N, Coleman LA, Miller RR, Garcia Garayoa E, Praestgaard J, Perry RG, Recknor C, Fogarty CM, Arai H, Chen LK, Hashimoto J, Chung YS, Vissing J, Laurent D, Petricoul O, Hemsley S, Lach-Trifilieff E, Papanicolaou DA, Roubenoff R. Rooks D, et al. Among authors: papanicolaou da. JAMA Netw Open. 2020 Oct 1;3(10):e2020836. doi: 10.1001/jamanetworkopen.2020.20836. JAMA Netw Open. 2020. PMID: 33074327 Free PMC article. Clinical Trial.
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Oskarsson B, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AI, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano CD, Williams VSL, Vissing J, Auberson LZ, Wu M, de Vera A, Papanicolaou DA, Amato AA; RESILIENT Study Group. Hanna MG, et al. Among authors: papanicolaou da. Lancet Neurol. 2019 Sep;18(9):834-844. doi: 10.1016/S1474-4422(19)30200-5. Lancet Neurol. 2019. PMID: 31397289 Clinical Trial.
Neuroendocrine aspects of chronic fatigue syndrome.
Papanicolaou DA, Amsterdam JD, Levine S, McCann SM, Moore RC, Newbrand CH, Allen G, Nisenbaum R, Pfaff DW, Tsokos GC, Vgontzas AN, Kales A. Papanicolaou DA, et al. Neuroimmunomodulation. 2004;11(2):65-74. doi: 10.1159/000075315. Neuroimmunomodulation. 2004. PMID: 14758052 Review.
Interleukin-6: the endocrine cytokine.
Papanicolaou DA, Vgontzas AN. Papanicolaou DA, et al. J Clin Endocrinol Metab. 2000 Mar;85(3):1331-3. doi: 10.1210/jcem.85.3.6582. J Clin Endocrinol Metab. 2000. PMID: 10720086 No abstract available.
Euthyroid Sick Syndrome and the role of cytokines.
Papanicolaou DA. Papanicolaou DA. Rev Endocr Metab Disord. 2000 Jan;1(1-2):43-8. doi: 10.1023/a:1010060303031. Rev Endocr Metab Disord. 2000. PMID: 11704991 Review. No abstract available.
The pathophysiologic roles of interleukin-6 in human disease.
Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. Papanicolaou DA, et al. Ann Intern Med. 1998 Jan 15;128(2):127-37. doi: 10.7326/0003-4819-128-2-199801150-00009. Ann Intern Med. 1998. PMID: 9441573 Review.
Advances in the diagnosis and treatment of Cushing's syndrome.
Tsigos C, Papanicolaou DA, Chrousos GP. Tsigos C, et al. Among authors: papanicolaou da. Baillieres Clin Endocrinol Metab. 1995 Apr;9(2):315-36. doi: 10.1016/s0950-351x(95)80354-8. Baillieres Clin Endocrinol Metab. 1995. PMID: 7625987 Review.
57 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page